TRANSCATHETER AORTIC HEART VALVE IMPLANTATION
EVOLUT PRO+ SYSTEM
Built upon the proven Evolut platform1, the Evolut PRO+ system offers the lowest delivery profile for 23-29 mm valves, excellent hemodynamics, the broadest annulus range,* and advanced sealing with an external tissue wrap.
Data on file (>20 clinical trials with over 20000 patients enrolled).
Broadest annulus range based on CT derived diameters for self-expanding valves.
Popma JJ. SURTAVI: Two Year Complete Results from a Randomized Trial of a Self-expanding Transcatheter Heart Valve vs. Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk. Presented at TCT 2018; San Diego, CA.